Tested, Published & NOW PATENTED

p40 & Uroplakin II

november-archives

Lung SqCC stained with p40 (M)

p40 (M)

• Patented monoclonal antibody exclusive to Biocare

• Superior specificity vs. p63: significantly less background1

• Stained 97% of lung Squamous CC2

• Stained 0% adenocarcinoma2

• U.S. Patent 9,428,576 issued 30th August 2016

Buy p40
Uroplakin II bladder cancer

Uroplakin II (M)

• Patented monoclonal antibody exclusive to Biocare

• 100% specific for urothelial carcinoma3

• Clone BC21: greater sensitivity than AU1 clone (UPIII)4

• UPII+p40+GATA3: highest sensitivity differential Dx5

• U.S. Patent 9,429,577 issued 30th August 2016

Buy Uroplakin II

References:
1. J Cutan. Pathol. 2014 Nov;41(11):839-45 2. In House Study 3. Tian W. et al. Hum. Pathol. 2015 Jan;46(1):58-64 4. Li W. et al. Am J Clin Pathol. 2014 Dec;142(6):864-71 5. Leivo MZ. et al. Pathology. 2016 Oct;48(6):543-9